Breast Cancer Information

Are Obese Women Getting Short-Changed By Chemotherapy Treatments?


How much chemotherapy does an obese woman need? Typically an obese woman with breast cancer would receive reduced doses of chemotherapy as they battle breast cancer.

Back in June of 2005, a study published in the Archives of Internal Medicine concluded that obese women should receive chemotherapy based on their actual weight, and not in reduced as amounts as it the standard practice.

And now again a study presented in the August 2005 edition of Lancet claims that doctors should not reduce chemotherapy doses for obese women when no receptors for the hormone oestrogen have been found on the breast cancer cells. This type of cancer is called oestrogen-receptor negative.

Clinicians often reduce chemotherapy doses for obese patients because of worries about how the treatment may react with the patient and affect their overall health.

According to the study's director Marco Colleoni of the European Institute of Oncology, Italy, and his colleagues, reducing the first course of chemotherapy for obese patients with oestrogen-receptor negative breast cancer proves "detrimental".

Colleoni and his team looked at the relation between body-mass index (BMI), chemotherapy dose reduction, oestrogen receptor expression, and outcome for pre-menopausal women with breast cancer by examining data from four randomized trials.

They found that 97 out of 249 obese patients received less than 85% of protocol specified dose during the first course of chemotherapy compared with patients with normal and intermediate BMI.

Obese patients with oestrogen-receptor negative disease that received 85% or more of the first protocol specified dose had significantly better disease-free survival and overall survival than those who received less than 85% of the normally recommended dosage.

Yet, obese patients with oestrogen-receptor positive breast cancer who had reduced doses of chemotherapy did not have a significant difference in their outcome compared with those given the recommended chemotherapy doses.

And contrary to popular practice, the researchers also noticed that obese patients initially treated with protocol doses of chemotherapy did not have more toxicity than patients who received reduced doses.

Dr Marco Colleoni concluded that, "Our findings suggest that for women with ER-absent or ER-low tumours, reduction in chemotherapy dose should be avoided."

The message for obese women coping with cancer is to be aware of your risks and rights. Ask your doctor will she recommend lower doses of chemotherapy for you based on your weight and ask why.

Resources: Lancet, Archives of Internal Medicine

Health author and Stanford University graduate Naweko San-Joyz lovingly writes from her home in San Diego. Her works include Acne Messages: Crack the Code of Your Zits and Say Goodbye to Acne (ISBN: 0974912204) and Skinny Fat Chicks, Why We're Still Not Getting This Dieting Thing (ISBN: 0974912212). Naweko created the Noixia philosophy to help people enhance their lives by connecting with their inner-mysteries and inner-selves. Her works take often over-looked, yet viable research and transforms in into practical tools that people can use to improve their health. Get useful, but too often ignored women's health news by visiting http://www.Noixia.com, Where Beauty Means Health.


MORE RESOURCES:

Modesto Bee

Q&A: Dr. Ernie Bodai, on global breast cancer stamp, Proposition 29
Modesto Bee
At 61, the Hungarian-born surgeon is actively promoting his global breast cancer stamp, campaigning for a tobacco tax on the June ballot and still treating patients as director of Kaiser Permanente's breast surgical services.

and more »


Standard Speaker

NEPA Survivors Group plans breast cancer benefit
Standard Speaker
The run benefits breast cancer awareness. Planning for the run are, front row, from left: Janine Denke, Lelly Valovich, and Tracy Clark. Back row: Maureen Minnick, Michael Valovich, Gabe Fritz, and Debbie Bridge. ERIC CONOVER/Staff Photographer Members ...



OregonLive.com

Thousands race for a cure for breast cancer
Ithaca Journal
Seventy five percent of the money raised stays local to support research and to help breast cancer patients and their families cope with the disease. "We have a nine-county region. The funds we raise today will serve people throughout the Twin Tiers," ...
Race for the Cure Draws Record NumbersWETM-TV
In aftermath of Komen funding flap, fewer sign up for raceDetroit Free Press
Komen Columbus Race for the Cure | Strength in numbersColumbus Dispatch
Helena Independent Record -St. Louis American -OregonLive.com
all 87 news articles »


News One

Breast Cancer Patient Allegedly Fired TWICE While Seeking Treatment
News One
By NewsOne Staff Connie Robinson has been fighting breast cancer for the past three years. That battle alone is enough for one person to endure. But, during that same period, Robinson says she has been fighting for her right to work.
Woman battling cancer was fired TWICE as she underwent treatmentDaily Mail
Va. woman with cancer says she was laid-off after diagnosisMy Fox 8

all 6 news articles »


Blocking DNA: HDAC inhibitor targets triple negative breast cancer
Medical Xpress
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research. Researchers from Tulane University Health ...

and more »


New developments in metastatic breast cancer to be reported at ASCO 2012 ...
The Imperfect Parent
Biotechnology pioneer company Genentech is moving ahead with its latest advance in the treatment of metastatic breast cancer. Data from its newest therapy, TDM-1, will be showcased at the premier annual cancer meeting in America called ASCO (American ...
Roche to outline cancer pipeline developments at ASCO 2012Zenopa

all 4 news articles »


Photoacoustics May Someday Allow Women to be Screened for Breast Cancer ...
HealthTechZone
A unique new technology may alert radiologists to breast cancer cells without exposing patients to radiation. Researchers in The Netherlands are testing a new technology that may allow radiologists to detect and see breast tumors with improved accuracy ...



Breast Cancer Effectively Treated with Chemical Found in Celery
ScienceBlog.com (blog)
Apigenin, a natural substance found in grocery store produce aisles, shows promise as a non-toxic treatment for an aggressive form of human breast cancer, following a new study at the University of Missouri. MU researchers found apigenin shrank a type ...
Breast cancer treated with celery extractFuturity: Research News
Apigenin, Found In Celery And Parsley, Could Help Fight Breast CancerHuffington Post

all 3 news articles »


3News NZ

Breast cancer lab samples swapped
Radio New Zealand
The Southern District Health Board is investigating how biopsy samples from two women with signs of possible breast cancer came to be swapped during testing earlier this year. The mistake led to one of the women having a breast removed when there was ...
Otago women hit by breast surgery botch-upOtago Daily Times
Chief apologises for biopsy bungleSouthland Times
Test Result Mix Up Results In Wrong Woman Having Breast RemovedSurgery.about.com
TopNews Arab Emirates -TVNZ -3News NZ
all 10 news articles »


HS6ST2 enzyme an important regulator of breast cancer cell-bone interactions
News-Medical.net
The researchers at VTT used RNA interference-based screening in breast cancer cells and found that an enzyme that modifies heparan sulfate glycosaminoglycans, HS6ST2, is an important regulator of breast cancer cell-bone interactions.

and more »

Google News

Mommy Home Jobs | Mommy Matters | index | site map
Copyright © MommyHomeJobs.com